Complife Next Events About Cosmetics
Start date
8 April, 2022
End date
8 April, 2022
Location:
Webinar
5 | 7 APRIL
@InCosmetics | STAND Q 120
A chance to meet.
Our international team will receive customers at the Complife stand – Q 120 – to illustrate the latest innovations in terms of business development and innovation, with a focus on the cosmetic market.
WE INVITE YOU TO RESERVE A MEETING WRITING AN E-MAIL BELOW.
SEND AN EMAIL TO OUR TEAM
8 APRIL – 10.30 am
WEBINAR IN COLLABORATION WITH HCI
Our colleagues Silvana Giardina and Andrea Poggi will held a webinar to deepen the different alternative approaches in the cosmetic safety evaluation.
The use of in vitro tests for the characterization of the toxicological profiles of substances and mixtures is a well-established but still evolving instrument.
The evolution of scientific knowledge, of the cellular and molecular biological processes, the progression of technologies, together with the need to satisfy the regulatory and safety requirements of the cosmetic sector, give the input to the development of new methods for increasingly complex and specific endpoints.
For the purposes of toxicological research, protocols using in vitro assay systems for the analysis of the potential for reproductive and developmental toxicity are now available, together with the protocols for the screening of the activities of possible endocrine disruptors, adaptable to different possible exposure patterns.
Furthermore, the in vitro investigations also embrace the environmental sector and let researchers to characterize the products not only in terms of safety for humans but also with regard to aquatic and terrestrial environments, being potentially susceptible to significant changes over time.
The in vitro experimental methods are therefore confirmed as an allied research tool in the cosmetic sector, able to offer investigative strategies integrated with adequate, sensitive and precise results.
To know more, book your participation to the webinar HERE
COMPLIFE. COMMITTED TO SCIENCE, COMMITTED TO YOU.
Get the latest news & updates
